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Abstract
In sub-Saharan Africa the highest overlap between malaria and HIV infections occurs in female
adolescents. Yet control activities for these infections are directed to different target groups, using
disparate channels. This reflects the lack of priority given to adolescents and the absence of an
accepted framework for delivering health and health-related interventions to this high-risk group.
In this paper it is argued that female adolescents require a continuum of care for malaria and HIV
– prior to conception, during and after pregnancy and that this should be provided through
adolescent services. The evidence for this conclusion is presented. A number of African countries
are commencing to formulate and implement adolescent-friendly policies and services and disease
control programs for malaria and HIV will need to locate their interventions within such programs
to ensure widespread coverage of this important target group. Failure to prioritize adolescent
health in this way will seriously limit the success of disease control programs for malaria and HIV
prevention.
Background
The current generation of adolescents – over one billion –
is the largest in history [1] and, far from representing a pic-
ture of health [2], many will suffer untimely disease and
death. HIV and malaria are responsible for much of the
disease burden affecting female adolescents, who suffer
disproportionately from these combined infections rela-
tive to other age groups. This is due to a high HIV inci-
dence during the period when many adolescents become
pregnant for the first time – an event which greatly
increases their susceptibility to Plasmodium falciparum
malaria [3]. Biological interactions between malaria and
HIV in pregnancy complicate therapy, which can also be
compromised by inappropriate adolescent health-seeking
behaviour. The public health importance of HIV and
malaria synergism is only now emerging. It has led to a
recommendation by the World Health Organization
(WHO) that the two disease programs should collaborate
to ensure integrated service delivery, especially within the
framework of reproductive health services [4]. A case has
also been made for linking disease control programs as a
more efficient and effective way for lowering the malaria
and HIV disease burden [5]. Nevertheless, it is difficult to
seen how these goals will be attained unless adolescents
are accorded a much higher priority by disease control
programs. In this paper we consider the justification, as
well as the challenges, of using common approaches to
improve delivery of HIV and malaria interventions to
female adolescents.
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Prevalence estimates for HIV infection [1] for 35 sub-
Saharan African countries, for young males and females
(15–24 years), are shown in Figure 1. Estimations are
often derived from sentinel surveillance of women attend-
ing antenatal care (ANC) and tend to overestimate preva-
lence in adolescents due to the selection of sexually active
[6] and less-educated groups [7]. Accepting this bias, in
every country, listed HIV prevalence is two to three times
higher among females than males. Having an older male
partner is associated with a modest increased HIV risk [8]
but probably does not explain a sex difference that occurs
uniformly across all countries and cultures and at all levels
of HIV endemicity. In Rakai, Uganda, only 12.4% of HIV
cases in 15–19 year olds was attributed to relationships
with men 10 years older [9]. Other sexually transmitted
infections (STIs) increase susceptibility to HIV but do not
account for the sex difference [10]. Host biological factors
may be critical [11]. Sexual maturation takes several years
to complete, but menarche is delayed amongst socio-dis-
advantaged girls, and many will be sexually active before
biological maturation is complete. Interventions that
delay the onset of sexual activity could reduce exposure at
a time of peak biological susceptibility to HIV and highest
risk of malaria in pregnancy.
Malaria is an important cause of adolescent hospital
admissions in many sub-Saharan African countries with
stable malaria transmission [12]. Malaria mortality in
African adolescents (both sexes) aged 10–14 years has
been estimated at over 45,000 deaths per annum [13]. The
highest prevalence of P. falciparum infection after child-
hood is also in young, mostly adolescent, women. Data
from Malawi (Table 1) shows that non-pregnant and preg-
nant adolescents had significantly higher parasite rates
than women above 19 years. Primigravidae also have a
markedly increased susceptibility to malaria [3]. Young
age and nulliparity in the same individual lead to greatly
increased malaria risk. This partly relates to reduced acqui-
sition of acquired malaria immunity in young individuals
[14] as well as the lack of parity-specific malaria immunity
acquired during the first pregnancy [15]. Risk factors for
symptomatic malaria in adolescents have not been stud-
ied, but both symptomatic and asymptomatic malaria
infection will contribute to the development of adolescent
and newborn anaemia [16]. HIV infection increases P. fal-
ciparum prevalence during pregnancy and this is marked
during the first pregnancy [17,18], which in Africa, is
nearly always in adolescence.
HIV and malaria interventions during adolescence
For both HIV and malaria there are effective interventions
for disease control. HIV and malaria frequently occur in
the same African populations and the same individuals,
yet control activities are directed to different target groups,
using different channels. Adolescent HIV prevention, with
its focus on behavioural change, has taken place largely
outside conventional health settings. Few HIV strategies
have been directed at pregnant adolescents and/or their
partners – an omission noted by a WHO Technical Con-
sultation on married adolescents [19]. In some African
countries, by the age of 19 years, half of all female adoles-
cents were in marital or permanent consensual unions [9]
that will almost certainly lead to pregnancy. In contrast,
malaria control efforts for women have focused on preg-
nancy, but not on adolescents and certainly not on ado-
lescents before they become pregnant. As a result, in many
sub-Saharan African settings, adolescents are often parasi-
taemic and anaemic when they first become pregnant. The
problem is that currently no overall strategy for adolescent
health has been approved for most African countries. The
burden of infection and disease among adolescents is of
sufficient magnitude that a way must be found to provide
services to this population. The existence of an appropri-
ate strategy would allow both HIV and malaria interven-
tions to be delivered within a common framework.
In traditional cultures, menarche often marks the transi-
tion from childhood to adulthood because it signifies
reproductive potential. Nevertheless, adolescence is a
physical process that takes a number of years and is usu-
ally completed by the late teens. This developmental proc-
ess should be encompassed within health care provision.
Pregnancy may punctuate that process, but during it, the
adolescent continues to grow physically and mentally
[20]. Strategies to reduce adolescent malaria or HIV
should, therefore, provide a continuum of care – before
conception, during and after pregnancy – encompassing
appropriate information, preventive and curative services.
For prevention, adolescents need access to condoms and
bednets, information on how to use them and, when and
where to go to deal with infection. Services must be avail-
able for infection monitoring and treatment, including
HIV testing and drug therapy for malaria, anaemia and
HIV-related opportunistic infections.
System improvements may not be strictly about adoles-
cent health services, but about support for ANC. Adoles-
cents need good access to pregnancy care and this includes
attendance for early pregnancy assessment and screening
for HIV and other sexually transmitted infections (STIs).
ANC presents an opportunity for HIV prevention, support
for discordant couples and care and referral for HIV-
infected adolescents. Early assessment is important as the
HIV positive individual needs to plan for anti-retroviral
treatment (ART) at delivery to prevent mother-to-child
transmission. It is also important for malaria control in
pregnancy. Intermittent preventive antimalarial treatment
(IPT) is the key malaria prevention policy that improvesPage 2 of 7
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[21]. Its effectiveness depends on the prevalence of HIV
infection [22]. It also depends on adherence to the treat-
ment regimen. Coverage with the standard two dose inter-
mittent sulphadoxine-pyrimethamine preventive malaria
treatment was lower in younger adolescents in the Shire
Valley, Malawi ≤ 17 years, 35.1% versus 18–19 years,
53.7%; p = 0.028, Verhoeff, personal communication),
and more than half of all pregnant adolescents received
inadequate antimalarial treatment. This demonstrates the
importance of pre-conceptual malaria health education
for girls. Adolescent mothers need instruction on how to
recognize and respond to infant malaria infection and
encouragement for using bednets for themselves and their
babies.
A major challenge for malaria control is to improve ado-
lescent health prior to the first pregnancy. For non-preg-
nant adolescents there are several conundrums. On
account of drug resistance, malaria combination therapy
with artemisinin derivatives is being introduced into an
increasing number of sub-Saharan African countries.
Artemisinin may be foeto-toxic and should be avoided,
except for symptomatic infections with multi-drug resist-
ant malaria, in the first trimester of pregnancy [23]. Inad-
vertent use or self-treatment by adolescent girls could
frequently occur in early pregnancy, before they recognise
their pregnancy. The issue of pregnancy testing adolescent
girls before treatment with potentially foeto-toxic drugs
will need to be considered.
A further issue is that the benefits of IPT extend to preg-
nant but not nulliparous adolescents who may be anae-
mic or parasitaemic at the start of their pregnancy. The use
of permethrin-treated bednets would protect against anae-
mia and parasitaemia during the first trimester, but ado-
lescent pregnant girls and their newborns are the least
likely to be net users [24].
Reaching the target population
The growing literature on adolescent-friendly health serv-
ices shows that adolescents have substantial concerns
about the delivery of interventions through health services
[25]. Almost universally, adolescents complain of lack of
information, confidentiality issues and judgmental atti-
tudes of service providers. There may be barriers of physi-
cal inaccessibility, service fees and non-supportive
community attitudes. A WHO consultation in Africa con-
cluded that adolescents had "a right to access health serv-
ices that can protect them from HIV/AIDS and from other
threats to their health and well-being, and that these serv-
ices should be made adolescent friendly" [26]. A WHO
Global Consultation on Adolescent Friendly Health Serv-
ices stated that government ministries should take appro-
priate action to ensure service provision for adolescents,
taking into account cost, epidemiological factors and
national health priorities [27]. The role of non-govern-
mental organizations and the private sector in spearhead-
ing adolescent projects was acknowledged, but alone,
these organizations cannot obtain sufficient coverage of
the adolescent population to substantially reduce the HIV
and malaria burden. Governments and disease control
programs must also consider training health care provid-
ers and modifying service delivery, so as to reduce barriers
to adolescent uptake.
The only country in Africa that has scaled up adolescent
health services is South Africa [28]. The South African
National Adolescent-Friendly Clinic Initiative has
strengthened the public health sector's ability to respond
to adolescent health needs by building capacity and estab-
lishing good clinical services which, eventually, will be
maintained by district and provincial health authorities. It
has demonstrated that an adolescent strategy is achievable
if there is political will. The South African approach may
not be suitable or affordable for lower income countries.
Well-focused services, training of key staff at selected sites,
outreach preventive services and good quality, adolescent-
oriented ANC are potential service reconfigurations that
could be used to extend coverage and increase uptake of
both HIV and malaria interventions without creating a
separate adolescent service.
What about young men? Available evidence suggests that
young men are not attracted to clinic services which are
perceived as "female "spaces [29]. In Ghana, for example,
Table 1: Malaria prevalence in non-pregnant and pregnant adolescents and adults in the Shire Valley, Malawi
Adolescent Adult
Non-Pregnant Pregnant * Non-Pregnant Pregnant*
% (n) % (n) % (n) % (n)
41.4(29)† 45.9 (122)‡ 20.3 (74) 35.4 (345)
* At delivery. Includes women who had received anti-malarials during pregnancy
† Difference with non-pregnant adults χ2 = 4.8; p = 0.028
‡ Difference with pregnant adults χ2 = 4.3; p = 0.04Page 4 of 7
(page number not for citation purposes)
Malaria Journal 2005, 4:2 http://www.malariajournal.com/content/4/1/276–89% of all adolescent clinic users were female [30].
Malaria is a reproductive health issue for females, but not
for males, and the disease burden of both malaria and
HIV infections is much lower in young males. Adolescent
females require more health-service based care than
males, and this should be reflected in service
configuration.
Creating an enabling environment to promote adolescent 
access to HIV and malaria interventions
Behavioural change, including appropriate health-seeking
practices, is essential for disease reduction. A decline in
HIV prevalence amongst adolescents has been reported
from Zambia [7], Uganda [31,32] and Tanzania [33] and
is attributed to changes in sexual behaviour. In Zambia,
between 1996 and 1999, urban adolescent males reported
less frequent sexual activity, fewer partners and were more
likely to have used a condom at the last sexual encounter.
Changes in these indices were less marked, or even deteri-
orated, among rural female adolescents [7]. Whether
behaviour change is the result of HIV programme inter-
ventions or other factors is unclear. Recent surveys in sub-
Saharan Africa reported that higher female education was
associated with lower HIV prevalence and lack of school-
ing with higher HIV incidence [6] and lower condom use
[34]. In western Uganda the proportion of illiterate
women fell from 41.6% to 24.6% over six years and may
have facilitated behavioural changes, but this link has
been little investigated. Illiterate females are likely to be
young and married, and to be in a situation where they
cannot reduce frequency of intercourse, negotiate con-
dom use or delay having children [19]. In a large preg-
nancy study in southern Malawi, 73% of 469 nulliparous
adolescents were illiterate [35]. They made significantly
fewer ANC visits, were less likely to have a supervised
delivery and had a higher risk of low birthweight. Reduc-
ing illiteracy and increasing educational and vocational
opportunities for female adolescents may be critical ena-
bling actions to promote risk reduction, to enhance their
social status and to decrease female vulnerability. [36]
Developing policies to support HIV and malaria control for 
female adolescents
Few developing countries have well-defined policies for
delivering care to the non-pregnant or pregnant adoles-
cent, especially for sexual health. Existing malaria guide-
lines also do not mention adolescents specifically [12].
An important aspect is the issue of the adolescent's right
to sexual and reproductive information and services vis à
vis the legitimate rights of parents to act in the best inter-
ests of a child, and the health care provider's right to work
within the law. These are issues of consent and confiden-
tiality for adolescents considered "minors" and under
parental control, or wives under their husband's or hus-
band's family's jurisdiction. When these issues are
ignored, adolescents cannot be assured of confidentiality,
and health workers are neither bound, nor protected by,
the legal system. Rights established in law, or by signed
Conventions (eg Convention of the Rights of the Child),
may not be implemented. Health policy falls down
because it is not explicit about the vulnerability of female
adolescents and does not challenge cultural and social
norms that can perpetuate the disease burden. Similarly,
encouragement for improving female literacy and educa-
tion may be lacking, reducing the supportive environment
for promoting uptake of adolescent health services and
safer sex. Advocacy is essential to co-ordinate law, custom
and health practice. At another level, it is important to
acknowledge that interventions for female adolescents
raise ethical issues that are avoided when they are
excluded from care. The policy of avoiding treatment of
adolescent girls (and adult women) because they might be
in the first trimester of pregnancy, raises issues of gender
discrimination and has been a serious issue for parasitic
disease control programs [37]. Reducing the necessity for
first trimester treatments for malaria can be achieved by
increasing efforts to redress the malaria burden prior to
pregnancy, but this requires reconfiguring service delivery.
HIV-positive adolescents who are at the start of their sex-
ual and reproductive lives might be prioritized to receive
anti-retroviral therapy, but their relative poverty and lack
of social status may lead to their exclusion from access to
this intervention.
Conclusions
For both HIV and malaria, although interventions are
available to reduce the disease burden, adolescents are not
prioritized. Effective policies and services are needed to
reduce the substantial disease burden they experience
from these infections. To secure this goal, concerted
action across HIV and malaria disease control programs is
required. This will reinforce support for adolescent pro-
grams rather than weakening them by multiple separate
activities, which can confuse implementation. A schedule
of activities is required that is reinforced by other systems
(e.g. education) to facilitate embedding it into a way of
life. These issues need to be addressed head-on by the
adolescent health community to achieve the focus
needed, and to establish the realistic steps forward. In the
short term, developing services to deliver HIV and malaria
interventions can act as a catalyst for addressing broader
adolescent health service needs. In the medium-term
adolescent-friendly health services provide the required
platform for the evaluation and delivery of future vaccines
and drug therapies for HIV, malaria [38] and other dis-
eases. In the longer term an inter-sectoral adolescent strat-
egy provides a basis for breaking the cycle of maternal-
child ill health.Page 5 of 7
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